These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17505590)

  • 41. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients.
    Nuytemans K; Rademakers R; Theuns J; Pals P; Engelborghs S; Pickut B; de Pooter T; Peeters K; Mattheijssens M; Van den Broeck M; Cras P; De Deyn PP; van Broeckhoven C
    Eur J Hum Genet; 2008 Apr; 16(4):471-9. PubMed ID: 18197194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re: LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Bonifati V; Wu-Chou YH; Schweiger D; Fonzo AD; Lu CS; Oostra B
    Neurology; 2008 Jun; 70(24):2348; author reply 2348-9. PubMed ID: 18541891
    [No Abstract]   [Full Text] [Related]  

  • 43. Wild-type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease.
    Sanjari Moghaddam H; Aarabi MH
    Mov Disord; 2018 Dec; 33(12):1876. PubMed ID: 30452792
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana.
    Cilia R; Sironi F; Akpalu A; Cham M; Sarfo FS; Brambilla T; Bonetti A; Amboni M; Goldwurm S; Pezzoli G
    J Neurol; 2012 Mar; 259(3):569-70. PubMed ID: 21842440
    [No Abstract]   [Full Text] [Related]  

  • 45. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.
    Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S
    Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany.
    Schlitter AM; Woitalla D; Mueller T; Epplen JT; Dekomien G
    J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):891-2. PubMed ID: 16788020
    [No Abstract]   [Full Text] [Related]  

  • 48. [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population].
    Shadrina MI; Illarioshkin SN; Bagyeva GKh; Bespalova EV; Zagorodskaia TB; Slominskiĭ PA; Markova ED; Kliushnikov SA; Limborskaia SA; Ivanova-Smolenskaia IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):46-50. PubMed ID: 18379513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease.
    Civitelli D; Tarantino P; Nicoletti G; Cirò Candiano IC; Annesi F; De Marco EV; Carrideo S; Rocca FE; Condino F; Spadafora P; Pugliese P; D'Asero S; Morelli M; Paglionico S; Annesi G; Quattrone A
    Clin Genet; 2007 Apr; 71(4):367-70. PubMed ID: 17470139
    [No Abstract]   [Full Text] [Related]  

  • 50. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
    Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
    Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutations.
    Ross OA; Toft M; Haugarvoll K
    Neurology; 2008 Jul; 71(4):303; author reply 303-4. PubMed ID: 18645174
    [No Abstract]   [Full Text] [Related]  

  • 52. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.
    Berg D; Schweitzer KJ; Leitner P; Zimprich A; Lichtner P; Belcredi P; Brüssel T; Schulte C; Maass S; Nägele T; Wszolek ZK; Gasser T
    Brain; 2005 Dec; 128(Pt 12):3000-11. PubMed ID: 16251215
    [No Abstract]   [Full Text] [Related]  

  • 53. A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease.
    Wang L; Guo JF; Nie LL; Xu Q; Zuo X; Sun QY; Yan XX; Tang BS
    Neurosci Lett; 2010 Jan; 468(3):198-201. PubMed ID: 19879329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
    Kay DM; Kramer P; Higgins D; Zabetian CP; Payami H
    Mov Disord; 2005 Aug; 20(8):1077-8. PubMed ID: 16001413
    [No Abstract]   [Full Text] [Related]  

  • 55. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.
    Lesage S; Dürr A; Tazir M; Lohmann E; Leutenegger AL; Janin S; Pollak P; Brice A;
    N Engl J Med; 2006 Jan; 354(4):422-3. PubMed ID: 16436781
    [No Abstract]   [Full Text] [Related]  

  • 56. New LRRK2 variants identified in Parkinson's disease.
    Tan EK; Schapira AH
    Eur J Neurol; 2011 Mar; 18(3):369-70. PubMed ID: 20629720
    [No Abstract]   [Full Text] [Related]  

  • 57. LRRK2 as a therapeutic target in Parkinson's disease.
    Tan EK; Schapira AH
    Eur J Neurol; 2011 Apr; 18(4):545-6. PubMed ID: 21199179
    [No Abstract]   [Full Text] [Related]  

  • 58. LRRK2: cause, risk, and mechanism.
    Paisán-Ruiz C; Lewis PA; Singleton AB
    J Parkinsons Dis; 2013; 3(2):85-103. PubMed ID: 23938341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.
    Carmine Belin A; Westerlund M; Sydow O; Lundströmer K; Håkansson A; Nissbrandt H; Olson L; Galter D
    Mov Disord; 2006 Oct; 21(10):1731-4. PubMed ID: 16817197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.
    Huang Y; Halliday GM; Vandebona H; Mellick GD; Mastaglia F; Stevens J; Kwok J; Garlepp M; Silburn PA; Horne MK; Kotschet K; Venn A; Rowe DB; Rubio JP; Sue CM
    Mov Disord; 2007 May; 22(7):982-9. PubMed ID: 17427941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.